StockNews.com upgraded shares of Exelon (NASDAQ:EXC – Free Report) from a sell rating to a hold rating in a research note issued to investors on Friday morning. A number of other equities analysts also recently commented on the company. Morgan Stanley reduced their price objective on Exelon from $45.00 to $42.00 and set an overweight […]